APG-2449 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Cancer; Non Small Cell Lung Cancer; Esophageal Cancer; Ovarian Cancer; Malignant Pleural Mesothelioma Intervention: Drug: APG-2449 Sponsor: Ascentage Pharma Group Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials